Gamaleya Research Institute of Epidemiology and Microbiology

Organization

A Russian institute that developed a two-dose adenovirus-vectored COVID-19 vaccine, publicly distributed before complete phase 3 trial data was available.

Mentioned in 1 video

Videos Mentioning Gamaleya Research Institute of Epidemiology and Microbiology

#137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines

#137 - Paul Offit, M.D.: An expert perspective on COVID-19 vaccines

Peter Attia MD

A Russian institute that developed a two-dose adenovirus-vectored COVID-19 vaccine, publicly distributed before complete phase 3 trial data was available.